Background: Few studies have comparatively assessed differences in the incidence of childhood cancer by race and ethnicity that could inform etiologic research. We aimed to identify disparities in the incidence of pediatric extracranial embryonal tumors by race and ethnicity in the United States using a population-based cancer registry. Methods: Cases of extracranial embryonal tumors among children age 0 to 19 years diagnosed between 2000 and 2010 were retrieved from the Surveillance, Epidemiology, and End Results Program 18 (n ¼ 8188). Age-standardized incidence rates and incidence rate ratios (IRRs) were obtained by race/ethnicity. Whites were the reference group. The percentage of families living below the poverty line by county was used to stratify by socioeconomic status (SES). Conclusions: Unique incidence patterns of childhood extracranial embryonal tumors exist by race and ethnicity in the United States. The interplay between race/ethnicity and genetics, epigenetics, and gene-environment interactions in the causation of these cancers deserves further investigation.
pathogenesis of these neoplasms might reflect unique geneenvironment interactions that could offer cues to their development. Our study aimed to identify differences in the incidence of pediatric extracranial embryonal tumors by race and ethnicity in the United States and to evaluate the potential modulatory environmental effect related to SES.
Methods

Study Population
Cases of children and adolescents (age 0 to 19 years) diagnosed with extracranial embryonal tumors between 2000 to 2010 were retrieved from 18 registries from the Surveillance, Epidemiology, and End Results Program (SEER 18) (12) . Death certificate-only and autopsy cases were excluded. Using the third edition of the International Classification of Childhood Cancer (ICCC-3) (13), the following tumors were selected: neuroblastoma and ganglioneuroblastoma (Group-IVa), retinoblastoma (Group-V), hepatoblastoma (Group-VIIa), malignant extra cranial and extragonadal germ cell tumors (extragonadal extracranial GCT, Group-Xb), malignant gonadal germ cell tumors (gonadal GCT, Group-Xc), nephroblastoma (Group VIa), and rhabdomyosarcoma (RMS, Group-IXa). Rhabdomyosarcomas were further stratified into four histological groups: embryonal, alveolar, RMS-not otherwise specified, and RMS-other, which includes pleomorphic, mixed type, and spindle cell histology.
The SEER population is comparable with the total US population with respect to measures of poverty and education but is somewhat more urban and purposefully inclusive of a higher proportion of foreign-born persons (14) . SEER 18 is estimated to represent 28% of the US population, 24.9% of whites, 25.6% of blacks, 30.6% of American Indians/Alaska Natives (AI/AN), 38 .4% of Hispanics, 66.5% of Native Hawaiians/Asian Pacific Islanders (API) (15).
Study Variables
We obtained information on age at diagnosis, sex, primary site, histologic type, stage, laterality, race, ethnicity, and county of residence directly from the SEER database. The SEER race recode and origin recode North American Association of Central Cancer Registries (NAACCR) Hispanic Identification Algorithm (NHIA) variables were used to create five race and ethnicity groups: white non-Hispanic (white), black non-Hispanic (black), white or black Hispanic (Hispanic), Native Hawaiian/Asian Pacific Islander (API), and American Indian/Alaska Native (AI/ AN). The two later races were not separated by ethnicity based on low expected frequency and SEER's recommendations (16) . Patients with race listed as "other" or "unknown" were excluded. An area-based indicator of SES ("percentage of families below poverty level") was retrieved from 2000 US Census variables and obtained for each individual based on the county of residence. On SEER public data, counties are the smallest unit for analysis. Census track variables are removed from the SEER public use research file because of confidentiality concerns of small-area analysis. We split the cohort based on the median value (8.79%), allowing for comparison of incidence rates by race/ethnicity stratified by SES (into advantaged and disadvantaged counties). There is currently no consensus in the United States regarding which area-based measures to use to measure or monitor socioeconomic inequalities in health (17) (18) (19) . However, existing literature suggests that "the validity of using area-based measures depends on the extent to which areas constitute meaningful geographic units" (20) . In addition, the Public Health Disparities Geocoding Project detected similar gradients of impact whether categories were generated using quintiles or a priori categorical cut-points (18) . Because our main objective was to show ethnic disparities, rather than economic disparities, we favored the use of a single-variable measure and median US value as the cutoff point for stratification by SES and evaluation for effect modification.
Statistical Analysis
Age-standardized incidence rates (ASIRs) were calculated using the 2000 US Population as standard and displayed as cases per 1 000 000 habitants. Incidence rate ratios (IRRs) and the corresponding 95% confidence intervals (CIs) and P values were obtained from SEER*Stat program (ver. 8.1.2) using the F-intervals test, the designated test for this purpose in the aforementioned program. Diagnoses with fewer than 10 cases by race/ethnicity subgroup were not interpreted. In stratified analyses (by race/ ethnicity and sex or SES), cells with five or fewer cases were not interpreted. The chi-square test (X 2 ) was used to determine association in contingency tables. A P value of less than .05 was considered statistically significant. All statistical tests were two-sided.
Results
Our cohort initially included 8343 individuals; 155 cases (1.9%) had race or ethnicity listed as "other" or "unknown" and were excluded. Thus, the final cohort comprised 8188 children (98.1%), with the following distribution by race/ethnicity: 52.7% white, 27.6% Hispanic, 11.8% black, 6.9% API, and 1.0% AI/AN (Table 1) .
Neuroblastoma
One thousand nine hundred seventy-four cases of neuroblastoma were observed (Table 1) . Male-to-female ratio was 1:1. Whites showed the highest age-standardized incidence rate (9.8/million) ( Table 2) Figure 1A ). When stratified by SES, all rates were slightly lower in disadvantaged groups compared with the advantaged counterparts, but the effect was not strong enough to suggest the presence of confounding or effect modification ( Figure 1A ). Point estimates showed trend for higher risk of retinoblastoma for blacks (IRR ¼ 1.22, 95% CI ¼ 0.98 to 1.51) and API 
Nephroblastoma
One thousand three hundred ninety cases of nephroblastoma were observed (Table 1) . Male-to-female ratio was 0.9:1. Blacks had the highest ASIR (6.4/million), but the IRR was not statistically significantly higher than for whites ( Figure 1B) . No confounding or effect modification by SES was noted (Table 2 , Figure 2C ).
Hepatoblastoma
Four hundred eighteen cases of hepatoblastoma were observed (Table 1) . Male-to-female ratio was 1.7:1. API and Hispanics had the highest ASIR (2.1/million and 1.9/million, respectively) while blacks had the lowest (0.7/million) ( Table 2 , Figure 1B ). The decreased incidence of hepatoblastoma observed in blacks was statistically significant (IRR ¼ 0.44, 95% CI ¼ 0.28 to 0.68). No confounding or effect modification by SES was noted (Table 2, Figure 2D ).
Rhabdomyosarcoma
One thousand one hundred eighty-seven cases of rhabdomyosarcoma were observed (Table 1) . Male-to-female ratio was 1.4:1. Distribution by histologic type was embryonal (50.0%), alveolar (34.8%), not otherwise specified (10.2%), and "other" Figure 1B) . Stratified analysis by SES showed no evidence of confounding or effect modification (Table 2, Figure 2E ). Analysis by histology revealed a lower incidence of embryonal rhabdomyosarcoma among Hispanics (IRR ¼ 0. 
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(5.0%). Blacks had the highest ASIR (5.3/million), but an IRR com-
Extracranial Germ Cell Tumors
Two thousand three hundred ninety-five cases of germ cell tumors were observed ( Figure 1D ). Blacks, API, and AI/AN showed statistically significant lower incidence of CGT compared with whites (blacks: IRR ¼ 0. Stratification of the IRR estimates for extracranial germ cell tumors by SES showed an accentuation of the effect observed for Hispanics among the disadvantaged subgroup and but no effect modification in the effects for blacks, API, AI/AN regardless of SES. Therefore, statistically significant effect modification by SES was not documented (Table 2, Figure 2F ). Analysis by tumor location revealed an incidence pattern for nongonadal extracranial GCT by race/ethnicity, distinct to that observed for all GCT combined and for gonadal GCT ( Figure 1D ), and more closely resembling the pattern observed for retinoblastoma ( Figure 1A) . Among nongonadal extracranial GCT, Hispanics showed statistically significant higher incidence (IRR ¼ 1.26, 95% CI ¼ 1.00 to 1.59) ( Figure 1D ) compared with whites, but the results for blacks and API did not reach statistical significance (blacks: IRR ¼ 1.26, 95% CI ¼ 0.93 to 1.69; API: IRR ¼ 1.39, 95% CI ¼ 0.99 to 1.92) ( Figure 1D) Table 3 summarizes the disease-specific incidence patterns observed in our study by race and ethnicity. Supplementary Table 2 (available online) summarizes the genetic and epigenetic drivers associated with the childhood cancers included in this study and allows comparing and contrasting pathways in common. For example, there are contrasting roles for 1p and MYCN in neuroblastoma vs retinoblastoma, as well as for 11p15 for nephroblastoma, rhabdomyosarcoma, and hepatoblastoma. However, as it relates to informing conclusions by race and ethnicity, after reviewing this literature, we can only highlight the near absent annotation of race and/or ethnicity in etiological studies sourcing genetic and epigenetic drivers of childhood cancers.
Summary of Findings
Discussion
Our study reveals remarkable ethnic and racial disparities in the incidence of childhood extracranial embryonal tumors in the United States. We find of particular interest the contrasting incidence patterns identified by race and ethnicity for neuroblastoma, retinoblastoma, and extragonadal germ cell tumors on one side, and for nephroblastoma, rhabdomyosarcoma, and hepatoblastoma on another side, as well as a high incidence of gonadal germ cell tumors among Hispanics. Although minority groups in the United States are disproportionately represented in the lower SES groups (21) , interactions between race/ethnicity groups and SES were not identified. The observed disparities in cancer incidence invite consideration of how they might be driven by genetics, exposures, or gene-environment interactions.
Specific gene alterations and inherited syndromes have been identified for or associated with the embryonal tumors studied. Among these are some of the most potent Mendelian genetic effects in terms of penetrance, age of onset, and tissue specificity identified to date (10) . However, although genomewide association studies are shedding light into the contribution of genetic variations to etiology, causation has not always been clearly established, a large portion of childhood cancers remain unexplained, and variations in the prevalence of molecular determinants of embryonal cancers by race and ethnicity are understudied (11) . Furthermore, we now know that the genome of most embryonal tumors is relatively stable, compared with adult cancers; therefore, the accumulation of genetic alterations 
ARTICLE
as the main event in childhood cancer initiation (as compared with adult cancers) is becoming less appealing (9, 10) . A notable example is neuroblastoma. Genome-wide association studies have found specific mutations (at 6p22, 2q35, 1q21.1, and 11p15.4) to influence the likelihood of malignant transformation of developing neuroblasts, particularly for development of highrisk neuroblastoma (22) (23) (24) (25) . However, the findings are either not annotated for race and ethnicity or pertain only to Caucasian populations. Therefore, a unifying genetic hypothesis for the differences in incidence by race/ethnicity observed in this study remains elusive. Associations between childhood cancers and paternal and perinatal environmental exposures have been reported; however, the rarity of individual childhood cancers and the associated methodological constraints have hampered the ability to reach conclusions regarding putative environmental risk factors, beyond well-accepted causes such as viruses, high-dose ionizing radiation, and prior chemotherapy (11) . We examine the literature on paternal and perinatal environmental exposures disease by disease later on in the discussion.
There is increasing evidence of the role that epigenetic dysregulation plays in cancer initiation and progression (26) . Common characteristics of epigenetic alterations that make them appealing for explaining cancer risk at a population level and gene-environment interactions include their inheritability, potential reversibility, position effect, high frequency of alterations tolerated, and ability to be modified by the environment. Additional inherited and sporadic mutations may also contribute to or complement epigenetic dysregulation. Regarding embryonal tumors in particular, embryonal cells of various backgrounds may yield distinct tumor phenotypes according to their constitutional genetic background, the developmental stage of the cell, and their sensibility to dysregulation of epigenetic mechanisms or environmental exposures associated with specific developmental stages (26, 27) . Also, epigenetic dysregulation has been identified to play a role in the pathogenesis of all embryonal tumors included in this study (27) (28) (29) (30) (31) . Finally, in adults, epigenetic changes have been documented as able to explain common cancer risk and gene-environment interactions better than genetic changes (26) . Therefore, after completing this exploratory analysis and reviewing the literature, we favor epigenetic dysregulation, as a result of either inheritance or perinatal exposures, as the biologic model currently most suitable for explaining the differential incidence patterns observed in our study by race and ethnicity. However, our capacity to deepen into this hypothesis is hampered by the limited annotation of race and ethnicity in childhood genetic and epigenetic studies, as well as the observational nature of our study.
We now compare our point estimates and incidence trend results to disease-specific comparative literature available by race and ethnicity. Our data reveal strong evidence for differential incidence of neuroblastoma by race and ethnicity in the United States, with lower incidence in all minorities compared with whites, a finding previously documented for black infants (7) but otherwise only implied (29, 32, 33) . Epidemiologic studies of neuroblastoma considering ethnic, geographic, and environmental factors have shown conflicting results or remained inconclusive (34, 35) . More commonly accepted associations include residence in higher-income countries and belonging to a population with greater medical surveillance, among others (33) . The role of SES remains controversial (33) and was not supported in our results. Internationally, neuroblastoma shows high variability in incidence rates (34) , with high incidence reported in North America, Europe, Japan, and Australia and low incidence in Africa, Asia, and Latin America (36) . Detection bias is frequently proposed as the underlying hypothesis; however, we did not detect differences in frequency of localized vs regional or distant disease by race/ethnicity (expect for API-a smaller group). This argues against detection bias to explain the increased incidence of neuroblastoma among whites.
Interestingly, a reverse pattern was observed for retinoblastoma by race and ethnicity. In the United States, a higher incidence of retinoblastoma in blacks compared with whites has been previously described (32, 37, 38) . Retinoblastoma is the classic example for Knudson's two-hit hypothesis. However, the documented stability of the retinoblastoma genome and the increasing understanding of the role of epigenetic dysregulation in cancer initiation and promotion are shifting paradigms for this disease (28) . We observed a higher incidence of bilateral retinoblastoma among Hispanics. Wong et al. recently reported similar results and perceived the findings to result from a lack of a decline in the incidence of bilateral retinoblastoma among Hispanic males compared with white males during the study period (1992 to 2009) and differential access to advances in medical technology, such as prenatal testing, in the United States (39) . However, the paternal origin of most new germline RB1 mutations suggests that differential perinatal exposures (affecting spermatogenesis or imprinting in the early embryo) could play a role among Hispanic males (10) . In the case of sporadic (unilateral) retinoblastoma, the stable incidence in the United States has suggested the absence of a role for environmental factors such as dietary intake and infections (40) . However, a recent case-control study reported an increased risk of unilateral retinoblastoma among children born to US-born Hispanic mothers (odds ratio [OR] ¼ 1.34, 95% CI ¼ 1.01 to 1.77) (41) . Two others reported associations to maternal health and reproductive factors, such as maternal active smoking during pregnancy and human papillomavirus infection (42, 43) . In addition, the incidence of unilateral retinoblastoma has been noted to vary between countries considerably more than the hereditary form (34, 41) , and high incidence has been reported in Mexico (44) and Guatemala (45) , among other Latin American, Asian, and African countries (36) . Therefore, the international variation in incidence suggests a multifactorial process, where ethnicity, race, and the environment possibly play a role (34) .
The incidence of nephroblastoma was statistically significantly lower for Hispanics and API compared with whites. Although nephroblastoma used to be considered the "index childhood cancer" because of its homogeneity in incidence, there is increasing evidence of geographic variation (29, 36, 46 (48) . Other studies have also suggested a higher incidence of nephroblastoma in blacks (6, 35, 36) and postulated race rather than geography as a risk factor (34, 49) . Wilms tumor is the classic example of a childhood cancer arising in the context of an imprinting (epigenetic) disorder. While there is improved knowledge about the role of genetic and epigenetic factors in its etiology (29) , little is known about racial and ethnic differences (49) ; only a few perinatal and environmental risk factors have been identified, including maternal exposures to pesticides, maternal hypertension, gestational age, high birth weight, preterm birth, and birth order (34,50).
For rhabdomyosarcoma, we observed a pattern very similar to that observed for nephroblastoma. Analysis by histology revealed stronger associations for embryonal than alveolar tumors, a finding consistent with the different biology of these tumors (51) . Similar to Wilms tumor, embryonal rhabdomyosarcoma frequently has loss of heterozygosity in the 11p15 locus, a region that contains several imprinted genes that have been implicated in oncogenesis (51) (52) (53) . In contrast, the hallmark of alveolar rhabdomyosarcoma is the presence of a specific translocation (PAX3-FOXO1 or PAX7-FOXO1) (54) . High birth weight, overgrowth disorders, and pubertal androgens (a factor specific to adolescent males) have been associated with an increased risk of rhabdomyosarcoma (51, 55) . In contrast to our findings, little variation in the international incidence of rhabdomyosarcoma and Wilms tumor has been reported (34), although these conditions frequently rank high in hospital-based series from African countries (56, 57) .
Interestingly, the incidence patterns observed for hepatoblastoma by race and ethnicity were the opposite of those observed for nephroblastoma and rhabdomyosarcoma. Common pathways implicated in the risk of these three neoplasms include epigenetic changes and imprinting of genes (29, 31, 58, 59) , but the differences in these mechanisms by race and ethnicity are not documented. A recent study found black infants to have higher IGF1 methylation, compared with their nonblack counterparts, and the methylation of IGF1 to partially mediate the association between black race and age-adjusted birth weight (60) . An underlying reason for those racial differences in DNA methylation is not known, but variation in the intrauterine environment, maternal or fetal metabolism, or environmental exposures is thought to play a role. IGF2 methylation could also differ by race/ethnicity and influence the risk of nephroblastoma, rhabdomyosarcoma, and hepatoblastoma.
Finally, the overall incidence of GCT was higher for Hispanics and lower for all other minorities compared with whites. The pattern observed for gonadal GCT mimicked the pattern seen for GCT overall (because of the predominance of gonadal GCT among extracranial GCT overall). However, the incidence pattern observed by race/ethnicity for extragonadal extracranial GCT resembled that seen for retinoblastoma and was clearly distinct from that observed for GCT overall. The pattern of genetic and epigenetic changes and exposures that could potentially influence the development of early-onset tumors (such as retinoblastoma, neuroblastoma, nephroblastoma, hepatoblastoma, rhabdomyosarcoma, and extragonadal extracranial GCT) is likely different than the sequence of events driving later-onset gonadal GCT, as illustrated by their incidence patterns by age, presence/absence of effect modification by sex, and distribution by race/ethnicity. However, little is known about either mechanism, particularly by race/ethnicity. Cryptorchidism remains the only confirmed risk factor for testicular germ cell tumors and genetic syndromes (such as Klinefelter, Sywer, and Turner), the main risk factors for extragonadal extracranial GCT (7) . The role of epigenetics in the biology of gonadal GCT is now better characterized, particularly regarding the hypomethylation of specific genes (61) .
The strength of our study stems from the high completeness and accuracy of the SEER data. Limitations of the study include its descriptive nature, which allows exploratory analyses and development of hypotheses, but not determination of causality. Second, the small number of incident cases in smaller minority groups (such as AI/AN), as well as the small number of cases when diagnosis is subdivided by histology or topography, limits the interpretation of results. Third, there is a possibility of ecological fallacy because we have used area-based SES measures and the minimal possible unit of analysis, that is, the county of residence, could be too heterogeneous (see the "Methods" for details). Finally, although we believe epigenetics may be best suited to explain some of the trends observed, the interpretation of our results was hindered by the paucity of race and ethnicity annotation in genetic and epigenetic studies of embryonal tumor biology.
In conclusion, we identified unique incidence patterns of childhood extracranial embryonal tumors by race and ethnicity in the United States, which could provide cues to etiological research. The interplay between race/ethnicity and genetics, epigenetics, and gene-environment interactions in the causation of these cancers deserves further investigation. We hope our results will encourage researchers to consider and better annotate race and ethnicity in childhood cancer etiologic studies.
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